Fundación Cardiovascular de Colombia

Floridablanca 681002

0 studies enrolling now · 6 studies all time

What they study most

Atrial Fibrillation, Chronic Heart Failure With Preserved Ejection Fraction, Gout, Heart Failure, Hemorrhage, Percutaneous Coronary Intervention, Secondary Prevention, Stroke

Studies at this site

• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
• A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study) — Completed
• Reversal of Dabigatran Anticoagulant Effect With Idarucizumab — Completed